<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">The Effect of Photodynamic Therapy Using Indole-3-Acetic Acid and Green Light on Acne Vulgaris</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Korean Dermatological Association and The Korean Society for Investigative Dermatology (KAMJE)</publisher>
				<availability status="unknown"><p>Copyright Korean Dermatological Association and The Korean Society for Investigative Dermatology (KAMJE)</p>
				</availability>
				<date type="published" when="2012">2012</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>M.D</roleName><forename type="first">Sun</forename><forename type="middle">Young</forename><surname>Huh</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Seoul National University College of Medicine</orgName>
								<address>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>M.D</roleName><forename type="first">Jung-Im</forename><surname>Na</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Seoul National University Bundang Hospital</orgName>
								<address>
									<settlement>Seongnam</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Seoul National University College of Medicine</orgName>
								<address>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>M.D</roleName><forename type="first">Chang-Hun</forename><surname>Huh</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Seoul National University Bundang Hospital</orgName>
								<address>
									<settlement>Seongnam</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Seoul National University College of Medicine</orgName>
								<address>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>M.D</roleName><forename type="first">Kyoung-Chan</forename><surname>Park</surname></persName>
							<email>gcpark@snu.ac.kr</email>
							<affiliation key="aff2">
								<orgName type="institution">Seoul National University Bundang Hospital</orgName>
								<address>
									<settlement>Seongnam</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Seoul National University College of Medicine</orgName>
								<address>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Department of Der-matology</orgName>
								<orgName type="institution">Seoul National University Bundang Hospital</orgName>
								<address>
									<addrLine>300 Gumi-dong, Bundang-gu</addrLine>
									<postCode>463-707</postCode>
									<settlement>Seongnam</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">Department of Dermatology</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">The Effect of Photodynamic Therapy Using Indole-3-Acetic Acid and Green Light on Acne Vulgaris</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Annals of Dermatology</title>
						<title level="j" type="abbrev">Ann Dermatol</title>
						<idno type="ISSN">1013-9087</idno>
						<idno type="eISSN">2005-3894</idno>
						<imprint>
							<publisher>Korean Dermatological Association and The Korean Society for Investigative Dermatology (KAMJE)</publisher>
							<biblScope unit="volume">24</biblScope>
							<biblScope unit="issue">1</biblScope>
							<biblScope unit="page">56</biblScope>
							<date type="published" when="2012" />
						</imprint>
					</monogr>
					<idno type="DOI">10.5021/ad.2012.24.1.56</idno>
					<idno type="PMID">22363156</idno>
					<idno type="PMCID">PMC3283851</idno>
					<ptr type="open-access" target="http://synapse.koreamed.org/Synapse/Data/PDFData/0140AD/ad-24-56.pdf" />
					<note type="submission">Received April 26, 2011, Revised July 22, 2011, Accepted for publication July 25, 2011 *This study was supported by LG Life Sciences.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T21:26+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Acne</term>
					<term>Green light</term>
					<term>Indole-3-acetic acid</term>
					<term>Photodynamic therapy</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Background: Photodynamic therapy (PDT) using topical aminolevulinic acid (ALA) has increasingly been used for the treatment of acne vulgaris and several studies have shown its clinical efficacy. However, ALA-PDT needs a relatively long incubation period and is frequently associated with adverse effects. Indole-3-acetic acid (IAA) has been introduced as a new photosensitizer for the treatment of acne in recent study. IAA-PDT requires only a short incubation period and the procedure is relatively painless in contrast to ALA-PDT. Objective: To investigate the efficacy and safety of IAA-PDT in the treatment of acne. Methods: Twenty-five patients with facial acne lesions were enrolled in this study. IAA-PDT was performed for five sessions at 1-week intervals (week 0∼4). IAA was treated with 15 minute occlusion, and green light was given for 15 minutes. Clinical efficacy was determined by evaluating acne lesion counts, severity grading, and the Dermatology Life Quality Index (DLQI) at week 0, 2, 4, and 5. Sebum secretion and erythema index was measured by Sebumeter and Mexameter, respectively, at baseline and one week after each treatment session (week 1∼5). Histopathological examination was performed at baseline and week 5. Adverse effects were recorded throughout the study. Results: All the patients completed the study. Numbers of both inflammatory and non-inflammatory acne lesions were significantly decreased. Acne severity grade and the DLQI showed significant reduction. Sebum secretion and erythema were also reduced. Histopathological examination showed a reduction in inflammatory reactions. No adverse effects were observed except for transient pruritus in one patient. Conclusion: PDT using IAA and green light was an effective, simple and safe treatment for acne. (Ann Dermatol 24(1) 56∼60, 2012</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p>Acne vulgaris is a common skin disorder causing chronic inflammation of the pilosebaceous units. Increased sebum production, abnormal keratinization of keratinocytes, colonization by Propionibacterium acnes and inflammation are thought to be the major pathogenic factors. The standard treatments for acne vulgaris include topical antimicrobials, topical retinoids, oral antibiotics, and oral isotretinoin. However, the effects of conventional therapies are limited due to antibiotic resistance and adverse effects such as irritation and teratogenicity of isotretinoin <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref> . Therefore, there is a need for the development of alternative treatments for acne. Currently, several authors have reported on the efficacy of photodynamic therapy (PDT) for acne <ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref> . PDT uses a photosensitizing drug activated by light, and causes cell destruction by the generation of reactive oxygen species 3 . 5-aminolevulinic acid (ALA) is commonly used and ALAinduced protoporphyrin IX has been shown to accumulate not only in the epidermal cells but also in the pilosebaceous units <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b6">7</ref> . Although its specific mechanism invol-ved has not been fully identified, it has been postulated that ALA-PDT causes phototoxic injury of sebaceous glands and inhibits sebum production, photodynamic killing of P. acnes, and reduction of follicular obstruction <ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref> . However, adverse effects such as pain, burning, stinging, erythema, exfoliation, and post-inflammatory hyperpigmentation are commonly observed in ALA-PDT <ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref> . Moreover, topical ALA has to be applied for a relatively long period under occlusion, since ALA requires time to convert into protoporphyrin IX and penetrate into the skin. In addition, strict photoprotection is required after the treatment procedure to avoid phototoxicity <ref type="bibr" target="#b7">8</ref> . Recently, indole-3-acetic acid (IAA) has been introduced as a new photosensitizer for PDT of acne <ref type="bibr" target="#b8">9</ref> . IAA is a member of the group of phytohormones called auxins <ref type="bibr" target="#b9">10</ref> . IAA alone is non-toxic in humans, however it can be activated after oxidative decarboxylation by horseradish peroxidase (HRP) and becomes cytotoxic <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b11">12</ref> . IAA can be activated not only by HRP but also by visible and ultraviolet light <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b12">13</ref> . Among various wavelengths of visible light, green light (520 nm) activated IAA most effectively <ref type="bibr" target="#b8">9</ref> . The pilot study of IAA-PDT using green light has been shown to be painless and does not require long incubation periods or photoprotection after the procedure in contrast to ALA-PDT <ref type="bibr" target="#b8">9</ref> . The purpose of this study was to evaluate the efficacy and tolerability of PDT using IAA and green light in the treatment of acne.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study design and patients</head><p>This study was performed between January 2010 and May 2010. The study was approved by the Institutional Review Board at our hospital and informed consent was obtained from all patients. Patients older than 16 years with acne lesions on the face were included. Patients were excluded if they had used any acne treatment during the previous 4 weeks or had any other skin diseases on the face. Pregnant and lactating women were also excluded. Twentyfive patients with facial acne lesions were enrolled. The patients were treated once a week for five consecutive weeks. Before application of IAA (0.015%), the skin was gently cleansed and IAA was applied for 15 minutes under occlusion. Then, green light (520 nm, 9 J/cm 2 ) was illuminated for 15 minutes.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Efficacy and safety evaluations</head><p>All patients were evaluated at baseline (week 0) and one week after each treatment session (week 1∼5). During each visit, standardized frontal and bilateral 45° side photographs were taken. The numbers of inflammatory (papules, pustules, nodules and cysts) and non-inflammatory (comedones) acne lesions were counted and severity was assessed based on the Korean Acne Grading System 14 at week 0, 2, 4, and 5. The severity score (grades 1∼6) was as follows: grade 1, ＜10 papules; grade 2, 11∼30 papules; grade 3, ＞31 papules and ＜10 nodules; grade 4, 11∼20 nodules; grade 5, 21∼30 nodules; and grade 6, ＞31 nodules <ref type="bibr" target="#b13">14</ref> .</p><p>Patients were asked to complete the Dermatology Life Quality Index (DLQI) questionnaire 15 at week 0, 2, 4, and 5. The DLQI is one of the most widely used instruments for assessing skin-related quality of life (QoL). It consists of 10 questions, and each item is scored on a four-point scale (0∼3 points). Higher scores indicate greater impairment of the patient's QoL. Objective skin measurements were performed at each follow-up visit. Erythema index of the acne lesions on both cheeks and forehead was measured with a Mexameter (MX-18; Courage &amp; Khazaka Electronic GmbH, Cologne, Germany). Sebum secretion on both cheeks and forehead was also measured with a Sebumeter Ⓡ (SM 815; Courage &amp; Khazaka) in a room with constant temperature (22∼23°C) and humidity (relative humidity 40∼45%).</p><p>The mean values of erythema index and sebum secretion were calculated by averaging the values obtained from both cheeks and forehead. At baseline and 1 week after the final treatment session (week 5), a 2 mm punch biopsy was performed from most acne lesions in 8 patients. Specimens were sectioned and stained with hematoxylin and eosin. Severity of inflammation was graded using a 0∼3 scale (grade 0: ＜5%, 1: 5∼30%, 2: 31∼70%, 3: ＞70%). Adverse effects were recorded throughout the study. The investigator graded the degree of erythema, scaling, hyperpigmentation, pruritus and pain at each visit, using a 0∼3 scale (0, none; 1, mild; 2, moderate; 3, severe).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p>Treatment effects were compared from each follow-up visit to the baseline scores using paired t-tests. Data were analyzed using the SPSS 15.0 software (SPSS Inc., Chicago, IL, USA). p-values of ＜0.05 were considered statistically significant.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients</head><p>Twenty-five acne patients were enrolled in the study. All patients were Korean women, and their mean age was 25.68±0.88 years (age range: 18∼34 years). All the  patients completed the study.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical assessment</head><p>Median reduction in numbers of inflammatory and non-inflammatory acne lesions from baseline to week 2, 4, and 5 are shown in <ref type="figure" target="#fig_2">Fig. 1A, B</ref>. There was a significant reduction in inflammatory acne lesion counts from week 2. Non-inflammatory lesion counts also showed significant reductions at week 2 and 5. The representative photographs showing the improvement observed on treated patient are shown in <ref type="figure" target="#fig_2">Fig. 1C</ref>. Acne severity assessed by the Korean Acne Grading System also showed significant reduction from 1.4 at baseline and 1.16 and 1.08 at week 2 and 5 (p=0.011 and 0.008, respectively). The mean DLQI score at baseline was 7.00 and significantly decreased to 5.92, 4.64, and 4.56 at week 2, 4 and 5, respectively. No significant adverse effects were reported. Only one subject had mild pruritus, which was selflimiting.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Objective assessment</head><p>The mean value of erythema index of the acne lesions showed a significant reduction throughout the study period from week 2 <ref type="figure" target="#fig_1">(Fig. 2)</ref>. Sebum secretion showed significant reduction at week 5 <ref type="figure" target="#fig_0">(Fig. 3)</ref>. Histopathological examination showed a significant reduction in inflammation at week 5 compared to baseline <ref type="figure" target="#fig_3">(Fig. 4)</ref>.  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p>IAA is a plant growth hormone and plays an important role in plant cell division, elongation and differentiation <ref type="bibr" target="#b9">10</ref> . IAA alone is a non-toxic substance, but can produce reactive oxygen species and a variety of free radicals when oxidized by HRP <ref type="bibr" target="#b10">11</ref> . Recent reports suggest that an IAA/HRP combination is cytotoxic to mammalian cells, and can be used as novel cancer therapy <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b16">17</ref> . Furthermore, light activated IAA has shown its anti-cancer activity in several studies <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b18">19</ref> . In addition to its potential as an anticancer drug, a recent study by Na et al. <ref type="bibr" target="#b8">9</ref> showed that IAA could be used as a novel photosensitizer for PDT of acne. Green light was chosen for the light source, since it activated IAA most effectively. Even low fluence (9 J/cm 2 ) of green light was sufficient to activate IAA. The combination of IAA and green light significantly decreased the colony count of P. acnes and S. aureus. Histological examination in mice back skin revealed that the combination of IAA and green light destroyed follicular epithelial cells. Fourteen patients were treated with a combination of IAA and green light 3 times at 2-week intervals and inflammatory lesion counts and sebum excretion significantly reduced <ref type="bibr" target="#b8">9</ref> . In the present study, we conducted IAA-PDT using green light 5 times at 1-week intervals, which was different from a previous study <ref type="bibr" target="#b8">9</ref> . We observed significant improvement through multidisciplinary approaches. Both inflammatory and non-inflammatory acne lesions were significantly decreased. The patients showed rapid improvement from week 2. Erythema index and sebum secretion were also significantly reduced after 5 treatment sessions. Additionally, histopathological examination was performed in 8 patients and the intensity of inflammation significantly decreased. Clinical and histological improvement shown in our study may be the effect of IAA itself or the result of antimicrobial activities on P. acnes <ref type="bibr" target="#b8">9</ref> . The strength of IAA-PDT is that it could be done very easily with only a short incubation period and does not require photoprotection. Furthermore, we experienced that the procedure was completely painless in contrast to ALA-PDT. One limitation of our study is that there were no control subjects. The lack of long-term follow-up data was another limitation. Therefore, further controlled studies are required to determine an effective regimen to ensure a long-lasting result. In conclusion, the combination of IAA and green light was shown to be a very simple, safe and effective treatment option for acne.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 3 .</head><label>3</label><figDesc>Sebum secretion at baseline and follow-up visits. *p ＜0.05 vs. baseline.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .</head><label>2</label><figDesc>Erythema index at baseline and follow-up visits. *p＜0.05 vs. baseline.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 1 .</head><label>1</label><figDesc>(A) The number of inflammatory acne lesions at week 0, 2, 4 and 5. *p＜0.05 vs. baseline. (B) Numbers of noninflammatory acne lesions at week 0, 2, 4 and 5. *p＜0.05 vs. baseline. (C) Clinical photographs of acne patient treated with IAA PDT (indole-3-acetic acid photodynamic therapy).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 4 .</head><label>4</label><figDesc>(A) Histopathological inflammation intensities at baseline and week 5. *p＜0.05 vs. baseline. (B) Histopathological changes of acne patients treated with IAA PDT (indole-3-acetic acid photodynamic therapy) at baseline and week 5 (H&amp;E, ×40).</figDesc></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Diane</forename><surname>Thiboutot</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Harald</forename><surname>Gollnick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vincenzo</forename><surname>Bettoli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brigitte</forename><surname>Dréno</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sewon</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">James</forename><forename type="middle">J</forename><surname>Leyden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alan</forename><forename type="middle">R</forename><surname>Shalita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vicente</forename><forename type="middle">Torres</forename><surname>Lozada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Diane</forename><surname>Berson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><surname>Finlay</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chee</forename><forename type="middle">Leok</forename><surname>Goh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">María</forename><forename type="middle">Isabel</forename><surname>Herane</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ana</forename><surname>Kaminsky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Raj</forename><surname>Kubba</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alison</forename><surname>Layton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshiki</forename><surname>Miyachi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Montserrat</forename><surname>Perez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jaime</forename><forename type="middle">Piquero</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marcia</forename><surname>Ramos-E-Silva</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jo</forename><forename type="middle">Ann</forename><surname>See</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Neil</forename><surname>Shear</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><surname>Wolf</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jaad.2009.01.019</idno>
		<idno type="PMID">19376456</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of the American Academy of Dermatology</title>
		<title level="j" type="abbrev">Journal of the American Academy of Dermatology</title>
		<idno type="ISSN">0190-9622</idno>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="S1" to="S50" />
			<date type="published" when="2009-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>Suppl. 5</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Antibiotics in acne: time for a rethink</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Simpson</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1365-2133.2001.04119.x</idno>
		<idno type="PMID">11251550</idno>
		<idno type="ark">ark:/67375/WNG-R0QGJQCC-N</idno>
		<idno type="istexId">4BDDB24AEE99031ABF7BE04799844B6C10017563</idno>
	</analytic>
	<monogr>
		<title level="j">British Journal of Dermatology</title>
		<title level="j" type="abbrev">Br J Dermatol</title>
		<idno type="ISSN">0007-0963</idno>
		<idno type="ISSNe">1365-2133</idno>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="225" to="227" />
			<date type="published" when="2001-02" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Topical ALA-Photodynamic Therapy for the Treatment of Acne Vulgaris</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wichai</forename><surname>Hongcharu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><forename type="middle">R</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Aghassi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kittisak</forename><surname>Suthamjariya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">Rox</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuchiao</forename><surname>Chang</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1523-1747.2000.00046.x</idno>
		<idno type="PMID">10951234</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Investigative Dermatology</title>
		<title level="j" type="abbrev">Journal of Investigative Dermatology</title>
		<idno type="ISSN">0022-202X</idno>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="183" to="192" />
			<date type="published" when="2000-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Photodynamic therapy of acne vulgaris with topical δ-aminolaevulinic acid and incoherent light in Japanese patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Ninomiya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Tajima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Ishibashi</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1365-2133.2001.04086.x</idno>
		<idno type="PMID">11260017</idno>
		<idno type="ark">ark:/67375/WNG-QCGS1V28-C</idno>
		<idno type="istexId">6DACDE44DF90FF5C4F623E933CE8972DE2BBB6F4</idno>
	</analytic>
	<monogr>
		<title level="j">British Journal of Dermatology</title>
		<idno type="ISSN">0007-0963</idno>
		<idno type="ISSNe">1365-2133</idno>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="575" to="579" />
			<date type="published" when="2001-03" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Pollock</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Stringer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Bojar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Goulden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">I</forename><surname>Stables</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">J</forename><surname>Cunliffe</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-2133.2004.06110.x</idno>
		<idno type="PMID">15377348</idno>
		<idno type="ark">ark:/67375/WNG-LDF2Z7P4-Z</idno>
		<idno type="istexId">5F76170F773E7295856DBD6477C097BA77A34C48</idno>
	</analytic>
	<monogr>
		<title level="j">British Journal of Dermatology</title>
		<title level="j" type="abbrev">Br J Dermatol</title>
		<idno type="ISSN">0007-0963</idno>
		<idno type="ISSNe">1365-2133</idno>
		<imprint>
			<biblScope unit="volume">151</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="616" to="622" />
			<date type="published" when="2004-09" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">X</forename><surname>Divaris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">H</forename><surname>Pottier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="891" to="897" />
			<date type="published" when="1990" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">H</forename><surname>Pottier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Photochem Photobiol B</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="275" to="292" />
			<date type="published" when="1992" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Clinical and research applications of photodynamic therapy in dermatology: Experience of the scottish PDT centre</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Moseley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Ibbotson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Woods</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Brancaleon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Lesar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Ferguson</surname></persName>
		</author>
		<idno type="DOI">10.1002/lsm.20369</idno>
		<idno type="PMID">16788933</idno>
		<idno type="ark">ark:/67375/WNG-MT0G176X-S</idno>
		<idno type="istexId">25C98F4A069ABD5F5B490032DFC204E81EB91ABE</idno>
	</analytic>
	<monogr>
		<title level="j">Lasers in Surgery and Medicine</title>
		<title level="j" type="abbrev">Lasers Surg. Med.</title>
		<idno type="ISSN">0196-8092</idno>
		<idno type="ISSNe">1096-9101</idno>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="403" to="416" />
			<date type="published" when="2006" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Indole-3-acetic acid: A potential new photosensitizer for photodynamic therapy of acne vulgaris</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jung-Im</forename><surname>Na</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">So-Young</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeong-Hye</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sang-Woong</forename><surname>Youn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chang-Hun</forename><surname>Huh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kyoung-Chan</forename><surname>Park</surname></persName>
		</author>
		<idno type="DOI">10.1002/lsm.21029</idno>
		<idno type="PMID">21412803</idno>
		<idno type="ark">ark:/67375/WNG-SKW05V7X-1</idno>
		<idno type="istexId">BA96CBFED1A4D85A68E4074993C5757722C725E2</idno>
	</analytic>
	<monogr>
		<title level="j">Lasers in Surgery and Medicine</title>
		<title level="j" type="abbrev">Lasers Surg. Med.</title>
		<idno type="ISSN">0196-8092</idno>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="200" to="205" />
			<date type="published" when="2011-03" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Cellular signaling: new insights into the action of the plant growth hormone auxin.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">H</forename><surname>Goldsmith</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.90.24.11442</idno>
		<idno type="PMID">8265570</idno>
		<idno type="PMCID">PMC47999</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/90/24/11442.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="11442" to="11445" />
			<date type="published" when="1993-12-15" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Oxidative activation of indole-3-acetic acids to cytotoxic species-a potential new role for plant auxins in cancer therapy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">K</forename><surname>Folkes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Wardman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Pharmacol</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="129" to="136" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Oxidation of indole-3-acetic acid by horseradish peroxidase induces apoptosis in G361 human melanoma cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dong-Seok</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sang-Eun</forename><surname>Jeon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kyoung-Chan</forename><surname>Park</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0898-6568(03)00091-3</idno>
		<idno type="PMID">14607278</idno>
	</analytic>
	<monogr>
		<title level="j">Cellular Signalling</title>
		<title level="j" type="abbrev">Cellular Signalling</title>
		<idno type="ISSN">0898-6568</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="81" to="88" />
			<date type="published" when="2004-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Light-Activated Indole-3-Acetic Acid Induces Apoptosis in G361 Human Melanoma Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dong-Seok</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">So-Young</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yun-Mi</forename><surname>Jeong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sang-Eun</forename><surname>Jeon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Myo-Kyoung</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sun-Bang</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jung-Im</forename><surname>Na</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kyoung-Chan</forename><surname>Park</surname></persName>
		</author>
		<idno type="DOI">10.1248/bpb.29.2404</idno>
		<idno type="PMID">17142972</idno>
		<ptr type="open-access" target="https://www.jstage.jst.go.jp/article/bpb/29/12/29_12_2404/_pdf" />
	</analytic>
	<monogr>
		<title level="j">Biological &amp; Pharmaceutical Bulletin</title>
		<title level="j" type="abbrev">Biol. Pharm. Bull.</title>
		<idno type="ISSN">0918-6158</idno>
		<idno type="ISSNe">1347-5215</idno>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2404" to="2409" />
			<date type="published" when="2006" />
			<publisher>Pharmaceutical Society of Japan</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Korean acne grading system</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">J</forename><surname>Sung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">S</forename><surname>Rho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">H</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Korean J Dermatol</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="1241" to="1247" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">K A</forename><surname>Basra</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Fenech</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">M</forename><surname>Gatt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">S</forename><surname>Salek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">Y</forename><surname>Finlay</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-2133.2008.08832.x</idno>
		<idno type="PMID">18795920</idno>
		<idno type="ark">ark:/67375/WNG-1NDFF0KJ-R</idno>
		<idno type="istexId">7A97FE9ED6F5A7AA3EB3F52CB4B36806170261B6</idno>
	</analytic>
	<monogr>
		<title level="j">British Journal of Dermatology</title>
		<idno type="ISSN">0007-0963</idno>
		<idno type="ISSNe">1365-2133</idno>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="997" to="1035" />
			<date type="published" when="2008-09" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Indole-3-Acetic Acids and Horseradish Peroxidase: A New Prodrug / Enzyme Combination for Targeted Cancer Therapy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Wardman</surname></persName>
		</author>
		<idno type="DOI">10.2174/1381612023394610</idno>
		<idno type="PMID">12052213</idno>
	</analytic>
	<monogr>
		<title level="j">Current Pharmaceutical Design</title>
		<title level="j" type="abbrev">CPD</title>
		<idno type="ISSN">1381-6128</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="1363" to="1347" />
			<date type="published" when="2002-07-01" />
			<publisher>Bentham Science Publishers Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Olga</forename><surname>Greco</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lisa</forename><forename type="middle">K</forename><surname>Folkes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Wardman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gillian</forename><forename type="middle">M</forename><surname>Tozer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gabi</forename><forename type="middle">U</forename><surname>Dachs</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.cgt.7700258</idno>
		<idno type="PMID">11129283</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/7700258.pdf" />
	</analytic>
	<monogr>
		<title level="j">Cancer Gene Therapy</title>
		<title level="j" type="abbrev">Cancer Gene Ther</title>
		<idno type="ISSN">0929-1903</idno>
		<idno type="ISSNe">1476-5500</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1414" to="1420" />
			<date type="published" when="2000-11" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Experimental Photodynamic Therapy for Liver Cancer Cell-Implanted Nude Mice by an Indole-3-acetic Acid and Intense Pulsed Light Combination</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kyoung-Chan</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">So-Young</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dong-Seok</forename><surname>Kim</surname></persName>
		</author>
		<idno type="DOI">10.1248/bpb.32.1609</idno>
		<idno type="PMID">19721241</idno>
		<ptr type="open-access" target="https://www.jstage.jst.go.jp/article/bpb/32/9/32_9_1609/_pdf" />
	</analytic>
	<monogr>
		<title level="j">Biological &amp; Pharmaceutical Bulletin</title>
		<title level="j" type="abbrev">Biol. Pharm. Bull.</title>
		<idno type="ISSN">0918-6158</idno>
		<idno type="ISSNe">1347-5215</idno>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1609" to="1613" />
			<date type="published" when="2009" />
			<publisher>Pharmaceutical Society of Japan</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Tumor apoptosis by indole-3-acetic acid/light in B16F10 melanoma-implanted nude mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">So-Young</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Myo-Kyoung</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sun-Bang</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jung-Im</forename><surname>Na</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kyoung-Chan</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dong-Seok</forename><surname>Kim</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00403-009-0938-6</idno>
		<idno type="PMID">19301020</idno>
		<idno type="ark">ark:/67375/VQC-QNPQDKG7-M</idno>
		<idno type="istexId">5342530F60B4B7AE87FFAB08C315549BE07E06C3</idno>
	</analytic>
	<monogr>
		<title level="j">Archives of Dermatological Research</title>
		<title level="j" type="abbrev">Arch Dermatol Res</title>
		<idno type="ISSN">0340-3696</idno>
		<idno type="ISSNe">1432-069X</idno>
		<imprint>
			<biblScope unit="volume">301</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="319" to="322" />
			<date type="published" when="2009-03-20" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
